Cirio acting for Karolinska Development AB (publ) in connection with its rights issue of shares

Cirio acts for Karolinska Development AB (publ) (“Karolinska Development”) in connection with its rights issue of shares with preferential rights for the company´s existing shareholders. The rights issue is subject to approval by an extraordinary general meeting to be held on 8 January 2026. Upon full subscription of the rights issue, Karolinska Development will receive approximately SEK 202.6 million before issue costs.

Karolinska Development is a Nordic investment company within life science listed on Nasdaq Stockholm.

Cirio acts for Karolinska Development with a team headed by Annika Andersson, together with Louise Åberg, Martin Näslund and Natalie Nilsson (Capital Markets and Public M&A).

For more information, please contact: